PURPLE BIOTECH LTD. (PPBT) Form 6-K — May 15, 2026
Purple Biotech Ltd. reported a net loss of $0.1 million for the first quarter of 2026, a significant improvement from the $0.5 million loss in the same period of 2025. This improvement was primarily driven by $2.2 million in net finance income, largely due to non-cash warrant-related fair value changes, which offset higher operating expenses. The company ended the quarter with $6.4 million in cash and short-term deposits, providing a runway into 2027 based on current management estimates.
Key figures
- Revenue
- 0
- Total Assets
- 14417000
- Cash Position
- 6400000
- Adjusted net loss
- 2169000
- Finance income net
- 2162000
- Ga expenses q1 2026
- 1021000
- Rd expenses q1 2026
- 1230000
- Shares outstanding ads
- 930677
- Adjusted operating loss
- 2158000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.